MIR29B2 and MIR29C host gene (MIR29B2CHG)

The MIR29B2 and MIR29C host gene (MIR29B2CHG, also known as FLJ35650) encodes a long non-coding RNA from which the microRNAs miR-29b-2 and miR-29c are generated[2]. These mature miRNAs are highly conserved gene regulatory elements that control gene expression post-transcriptionally, influencing processes such as epigenetic modifications (particularly DNA methylation), apoptosis, immune cell differentiation, and responses to viral and bacterial infections[1][2][3][4]. Alterations of miR-29 family expression are associated with cancer progression, immune dysregulation, multiple viral infections, and fibrotic diseases. The host gene itself is not a traditional drug target, but its products are under active investigation for therapeutic and diagnostic applications. Current research emphasizes the need to understand tissue-specific, subcellular, and disease-dependent roles of MIR29B2CHG-derived miRNAs to maximize therapeutic benefit while minimizing safety risks[2][1].

Other names

FLJ35650MIR29B2CHGMIR29B2 and MIR29C host gene

miR-29 mimics: restore miR-29 tumor suppressor function, promote demethylation of tumor suppressor genes. Anti-miRs: inhibit miR-29 in settings where miR-29 is pathogenic (context-dependent). Indirect modulation via small molecules that affect miR-29 expression (e.g., bortezomib induces miR-29).